Drug profile · INN
indinavir sulfate
CRIXIVAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
indinavir sulfate (CRIXIVAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN indinavir sulfate
Brand CRIXIVAN
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is indinavir sulfate?
indinavir sulfate (CRIXIVAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for indinavir sulfate?
CRIXIVAN is a marketed brand name for indinavir sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of indinavir sulfate?
indinavir sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.